3rd Quarter - Report
BROWNSTEIN HYATT FARBER SCHRECK, LLP for KNOA PHARMA
Client
Income
$60,000
Expenses
—
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Monitoring legislative and regulatory activities impacting the pharmaceutical industry public health initiatives related to opioid antagonist therapy
| Lobbyist | Covered position, as disclosed |
|---|---|
| ANDREW LITTMAN | — |
| LAUREN ALEXANDRA MISH | — |
| ALFRED MOTTUR | — |
| DEEMA TARAZI | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.